SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10

@article{Jeong2005SPECIESAD,
  title={SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10},
  author={E. Jeong and Y. Liu and H. Lin and M. Hu},
  journal={Drug Metabolism and Disposition},
  year={2005},
  volume={33},
  pages={785 - 794}
}
  • E. Jeong, Y. Liu, +1 author M. Hu
  • Published 2005
  • Biology, Medicine
  • Drug Metabolism and Disposition
Caco-2 cell lysate, and intestinal and liver microsomes derived from female humans and rats were used to compare and contrast the metabolism and disposition of raloxifene. In Caco-2 cell lysate, raloxifene 6-β-glucuronide (M1) was the main metabolite, although raloxifene 4′-β-glucuronide (M2) was formed in comparable abundance (58% versus 42%). In rat liver and intestinal microsomes, M1 represented about 76 to 86% of glucuronidated metabolites. In contrast, raloxifene 4′-β-glucuronide (M2) was… Expand
83 Citations
Raloxifene Glucuronidation in Human Intestine, Kidney, and Liver Microsomes and in Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism
  • 16
  • Highly Influenced
  • PDF
In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans
  • 20
  • PDF
Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9
  • 3
  • Highly Influenced
Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery
  • 10
Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment.
  • 21
  • PDF
Impact of Intestinal Glucuronidation on the Pharmacokinetics of Raloxifene
  • 29
  • PDF
Characterization of Raloxifene Glucuronidation: Potential Role of UGT1A8 Genotype on Raloxifene Metabolism In Vivo
  • 27
  • PDF
Relative Importance of Intestinal and Hepatic Glucuronidation—Impact on the Prediction of Drug Clearance
  • 101
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
  • 166
  • Highly Influential
  • PDF
Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 Model
  • E. Jeong, H. Lin, M. Hu
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • 2004
  • 65
  • PDF
Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model
  • 100
  • PDF
Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition
  • J. Chen, H. Lin, M. Hu
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • 2003
  • 213
  • PDF
Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
  • 82
  • PDF
Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model
  • M. Hu, J. Chen, H. Lin
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • 2003
  • 122
  • PDF
Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
  • Y. Liu, M. Hu
  • Chemistry, Medicine
  • Drug metabolism and disposition: the biological fate of chemicals
  • 2002
  • 220
  • PDF
UDP-glucuronosyltransferase activity in human liver and colon.
  • 179
Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon
  • 269
  • PDF
...
1
2
3
4
...